title: DSeq bulkRNA SCC25
design: SCC25 low passage cell linewere treated for 5 consecutive days with 100 M CB103 (# HY-135145 MedChemExpress-treated group) . After treatment, the cells were fixed for follow-up analyses. Total RNA was extracted and used for RNA sequencing library production or validated through RT-PCR.